Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6NWT

RORgamma Ligand Binding Domain

Summary for 6NWT
Entry DOI10.2210/pdb6nwt/pdb
DescriptorNuclear receptor ROR-gamma, 1,1,1,3,3,3-hexafluoro-2-[2-fluoro-4'-({4-[(pyridin-4-yl)methyl]piperazin-1-yl}methyl)[1,1'-biphenyl]-4-yl]propan-2-ol (3 entities in total)
Functional Keywordsorphan nuclear receptor, synthetic modulator, chemical probe, nuclear protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight58012.91
Authors
Strutzenberg, T.S.,Park, H.,Griffin, P.R. (deposition date: 2019-02-07, release date: 2019-07-10, Last modification date: 2023-10-11)
Primary citationStrutzenberg, T.S.,Garcia-Ordonez, R.D.,Novick, S.J.,Park, H.,Chang, M.R.,Doebellin, C.,He, Y.,Patouret, R.,Kamenecka, T.M.,Griffin, P.R.
HDX-MS reveals structural determinants for ROR gamma hyperactivation by synthetic agonists.
Elife, 8:-, 2019
Cited by
PubMed Abstract: Members of the nuclear receptor (NR) superfamily regulate both physiological and pathophysiological processes ranging from development and metabolism to inflammation and cancer. Synthetic small molecules targeting NRs are often deployed as therapeutics to correct aberrant NR signaling or as chemical probes to explore the role of the receptor in physiology. Nearly half of NRs do not have specific cognate ligands (termed orphan NRs) and it's unclear if they possess ligand dependent activities. Here we demonstrate that ligand-dependent action of the orphan RORγ can be defined by selectively disrupting putative endogenous-but not synthetic-ligand binding. Furthermore, the characterization of a library of RORγ modulators reveals that structural dynamics of the receptor assessed by HDX-MS correlate with activity in biochemical and cell-based assays. These findings, corroborated with X-ray co-crystallography and site-directed mutagenesis, collectively reveal the structural determinants of RORγ activation, which is critical for designing RORγ agonists for cancer immunotherapy.
PubMed: 31172947
DOI: 10.7554/eLife.47172
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.35 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon